Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
SAN DIEGO, Oct. 08, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the […]
MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue
MARIETTA, Ga., Oct. 08, 2024 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today highlighted the publication […]
TSX News -
PrairieSky Royalty Announces Conference Call for Q3 2024 Results
CALGARY, Alberta, Oct. 08, 2024 (GLOBE NEWSWIRE) — PrairieSky will release its Q3 2024 results on Monday, October 28, 2024 […]
Nasdaq Resumes Trading in BAIYU Holdings, Inc.
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading will resume in […]
Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show
KANSAS CITY, Kan., Oct. 08, 2024 (GLOBE NEWSWIRE) — Shane J. Schaffer, Chairman and CEO of Cingulate Inc. (NASDAQ: CING), […]
Tevogen Bio Highlights Promising Trial Data as CEO Leads Patient Advocacy at Capitol Hill, Pledging to Leverage Multi-Billion Dollar Company Assets to Combat Long COVID and Spearhead a New Wave of Medical Innovation
The primary study endpoints were related to safety. No dose-limiting toxicities or significant adverse events related to TVGN 489, including […]
Almadex Provides Update on its Paradise Project, Nevada
VANCOUVER, British Columbia, Oct. 08, 2024 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) is pleased to provide […]
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Quarter Ended September 30, 2024
ZTlido net sales for the quarter ended September 30, 2024 were in the range of $11.0 million to $13.0 million, […]
